Supplement Adverse Event Portal Should Speed Signals Of Problems
This article was originally published in The Tan Sheet
Executive Summary
FDA hopes the portal will spur “enhanced submission of AERs” and allow agency officials to determine more rapidly whether causal links exist between a product or ingredient and adverse events, says supplement programs chief Daniel Fabricant.